This common vitamin could help fight one of the deadliest brain cancers

GymNews.com brief · 46d ago · 1 min read · via sciencedaily.com

High-dose vitamin B3 is showing intriguing early promise as an addition to standard glioblastoma treatment, with 82% of patients in a small trial remaining progression-free after six months. Researchers believe niacin may help revive immune cells suppressed by the cancer, but lar

High-dose vitamin B3 is showing intriguing early promise as an addition to standard glioblastoma treatment, with 82% of patients in a small trial remaining progression-free after six months. Researchers believe niacin may help revive immune cells suppressed by the cancer, but lar This story matters for Health & Wellness readers tracking gym. Reported by sciencedaily.com. Read the full original at the source link below.

Originally reported by sciencedaily.com. GymNews.com curates and briefs the health & wellness stories that matter. Our editorial policy →
Get the daily gym signal

More from GymNews.com

Related ventures